AxialBridge Announces Collaboration Leveraging AI for Next-Generation Clinical Trial Technologies
Calgary, ALB, March 21, 2024. AxialBridge is pleased to announce its partnership with RxPx to launch the 'AI Clinical Buddy System', which will leverage Artificial Intelligence towards enhancing patient recruitment, adherence, diversity, and engagement in clinical trials. With co-investment from Digital, Canada's Global Innovation Cluster for digital technologies, the project is a powerhouse partnership between industry leaders and distinguished researchers in Canada and the United Kingdom. The AI Clinical Buddy System will help to reduce operational overheads and enhance patient physical and behavioural tracking to improve adherence, retention, and engagement using machine learning and persuasive, generative, and predictive AI approaches.
This project will be utilizing the platform in a proof-of-concept clinical trial and solution for chronic concussion therapies, the project will utilize fine-tuned large language models (LLMs) for clinical trials, conversational interfaces, adherence-prediction algorithms and classifications. The AI Clinical Buddy System will also increase equity, diversity, inclusion and overall participation in trials through personalized onboarding and engagement features for patients.
“Clinical trials are challenging to conduct, especially participant recruitment, retention and ensuring a diverse population. Axialbridge is thrilled to have the opportunity to work on a Canadian funded project to leverage AI as a solution to meet these challenges.” said Sabrina Ramkellawan.
The successful implementation of this AI-driven innovation has the potential to revolutionize completion, success and relevancy of clinical trials towards developing more effective medications and therapies for chronic conditions. By leveraging these opportunities and demonstrating the effectiveness of the proposed solution, the project team stands to position themselves as global leaders for AI-driven healthcare innovation.
Funders and Partners:
Digital, Canada’s Global Innovation Cluster for digital technologies, grows Canadian businesses through the development, adoption and deployment of Canadian-made technologies and by working with industry to develop a digitally skilled workforce to positively impact lives across our country. Through a powerful model that combines cross-sector collaboration, Canadian IP creation and results-based co-investment, they unlock the potential of Canadian industry to lead and succeed in the digital world. To date, DIGITAL has invested $510M in Canadian-led innovation and has 120+ products and services in development. As both the technical and commercial partner, AxialBridge is honoured to be working with RxPx, OPTT Health, uMed, Aparito, The University of British Columbia, York University, Caoimhe Vallely-Gilroy Consulting, Dr. Martin- Ginis, Dr. Nayebi, Dr. Mark Toshner and the University of Cambridge.
About AxialBridge
AxialBridge is a female-led bespoke organization dedicated to advancing novel therapeutics, devices and digital health platforms by providing a more targeted and customised approach, including strategic consulting and clinical trial management services up to commercialization, including reimbursement & market access strategies.
Our interdisciplinary team supports the acceleration and optimal success of emerging innovations and novel therapies in various therapeutic areas.
For further information, please direct inquiries to info@axialbridge.com.